Reporter Oct 30 2020
Histamine circuits in brain reward center
Oct. 29, 2020—Histamine — commonly associated with allergies — also has a signaling role in the brain’s reward center and may offer a novel target for treating addiction.
Self named VP for Clinical Research Networks and Strategy
Oct. 29, 2020—Wesley Self, MD, MPH, has been appointed Vice President for Clinical Research Networks and Strategy at Vanderbilt University Medical Center.
Lovly to chair foundation’s scientific leadership board
Oct. 29, 2020—Christine Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, has been named incoming chair of GO2 Foundation's Scientific Leadership Board (SLB).
VUMC researchers selected for inaugural FDA-AACR fellowship
Oct. 29, 2020—Henry Henderson III, PhD, and Justin Lo, MD, PhD, are members of the 2020-2021 inaugural class of FDA-AACR Oncology Educational Fellows.
New markers of colorectal cancer risk
Oct. 29, 2020—Vanderbilt epidemiologists identified new markers for colorectal cancer risk and characterized a previously unidentified tumor suppressor that regulates overall tumor volume in vivo.
Study finds areas without mask requirements have larger increase in COVID-19 hospitalizations
Oct. 27, 2020—All areas of Tennessee have seen a resurgence in hospitalized COVID-19 patients since early October, but hospitals that draw patients from counties without masking requirements are experiencing much sharper increases, according to a new analysis from researchers at Vanderbilt University Medical Center and Vanderbilt University School of Medicine.
Pediatrician at Monroe Carell Jr. Children’s Hospital at Vanderbilt urges caution this Halloween
Oct. 26, 2020—While most of 2020 has been pretty scary, Halloween doesn't have to be, say experts at Monroe Carell Jr. Children's Hospital at Vanderbilt.
National Academy of Medicine addresses urgent threats of COVID-19 and climate change at annual meeting
Oct. 26, 2020—The COVID-19 pandemic and climate change are twin calamities that cannot be resolved without global cooperation, consistent communication and leadership and urgent innovation by the scientific community.
COVID treatment studied by VUMC gains FDA approval
Oct. 26, 2020—Researchers at Vanderbilt University Medical Center played a key role in the development of remdesivir, the first drug approved by the U.S. Food and Drug Administration for the treatment of COVID-19.
Motor vehicle deaths increase despite fewer cars on the road during COVID-19
Oct. 26, 2020—Despite a decrease in the volume of cars on the road during the COVID-19 pandemic, the National Highway Traffic Safety Administration (NHTSA) reports that driving patterns and behaviors were riskier, leading to an increase in accident-related fatalities since April 2020.
